Corvus Pharmaceuticals (CRVS) Institutional Ownership

$11.62 -0.18 (-1.53%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$11.64 +0.02 (+0.17%)

As of 09/25/2026 07:30 PM Eastern

Compare

Current Institutional Ownership Percentage: 46.64%
Number of Institutional Buyers (last 12 months): 87
Total Institutional Inflows (last 12 months): $336.89M

Number of Institutional Sellers (last 12 months): 22
Total Institutional Outflows (last 12 months): $35.12M

Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	Tidal Investments LLC	136,276	$2.04M	0.0%	+26.4%	0.162%
9/9/2026	WINTON GROUP Ltd	23,200	$347K	0.0%	-12.8%	0.028%
9/9/2026	Engineers Gate Manager LP	36,019	$538K	0.0%	N/A	0.043%
9/9/2026	Integrated Wealth Concepts LLC	8,169	$122K	0.0%	N/A	0.010%
9/9/2026	Squarepoint Ops LLC	44,205	$660K	0.0%	-64.3%	0.053%
9/8/2026	Arizona State Retirement System	17,382	$260K	0.0%	N/A	0.021%
8/21/2026	Braidwell LP	2,126,298	$31.77M	1.2%	+21.3%	2.528%
8/20/2026	Ancora Advisors LLC	56,723	$847K	0.0%	+3.6%	0.067%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	74,369	$1.11M	0.0%	+1,116.0%	0.088%
8/19/2026	Wellington Management Group LLP	2,731,632	$40.81M	0.0%	+17.8%	3.247%
Get the Latest News and Ratings for CRVS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
8/17/2026	Seven Fleet Capital Management LP	82,890	$1.24M	0.0%	N/A	0.099%
8/17/2026	Bank of America Corp DE	757,798	$11.32M	0.0%	N/A	0.901%
8/15/2026	Jupiter Topco LLC	28,100	$420K	0.0%	N/A	0.033%
8/14/2026	ADAR1 Capital Management LLC	117,101	$1.75M	0.1%	N/A	0.139%
8/14/2026	Ancora Advisors LLC	56,723	$847K	0.0%	N/A	0.067%
8/14/2026	Legal & General Group Plc	41,697	$623K	0.0%	N/A	0.050%
8/14/2026	The Manufacturers Life Insurance Company	82,907	$1.24M	0.0%	N/A	0.099%
8/14/2026	Spruce Street Capital LP	231,585	$3.46M	0.0%	N/A	0.275%
8/13/2026	Polymer Capital Management HK LTD	263,662	$3.94M	0.2%	N/A	0.313%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	217,750	$3.25M	0.0%	N/A	0.259%
8/11/2026	Blue Owl Capital Holdings LP	608,600	$9.09M	1.4%	N/A	0.724%
8/11/2026	E Fund Management Co. Ltd.	11,491	$172K	0.0%	N/A	0.014%
8/10/2026	DCF Advisers LLC	637,500	$9.52M	1.7%	N/A	0.758%
8/8/2026	Meeder Asset Management Inc.	6,055	$90K	0.0%	N/A	0.007%
8/7/2026	BlackRock Inc.	7,138,811	$106.65M	0.0%	N/A	8.489%
8/7/2026	Deutsche Bank AG	74,529	$1.11M	0.0%	N/A	0.089%
8/7/2026	Mitsubishi UFJ Asset Management Co. Ltd.	3,200	$48K	0.0%	N/A	0.004%
8/7/2026	OneDigital Investment Advisors LLC	10,001	$149K	0.0%	N/A	0.012%
8/7/2026	Hikari Power Ltd	49,959	$746K	0.1%	N/A	0.059%
8/6/2026	Global Retirement Partners LLC	2,002	$30K	0.0%	N/A	0.002%
8/6/2026	Bank of New York Mellon Corp	202,609	$3.03M	0.0%	N/A	0.241%
8/6/2026	State of Wyoming	4,735	$71K	0.0%	N/A	0.006%
7/10/2026	Tema ETFs LLC	136,276	$2.04M	0.1%	+26.4%	0.162%
7/9/2026	Avity Investment Management Inc.	37,150	$555K	0.0%	+11.9%	0.044%
6/4/2026	Seven Fleet Capital Management LP	82,890	$1.21M	0.4%	N/A	0.099%
5/29/2026	Perceptive Advisors LLC	2,292,441	$33.54M	0.7%	+231.1%	2.726%
5/28/2026	Avidity Partners Management LP	115,000	$1.68M	0.3%	N/A	0.137%
5/20/2026	Vivo Capital LLC	2,805,816	$41.05M	3.4%	+25.6%	3.337%
5/18/2026	ADAR1 Capital Management LLC	87,901	$1.29M	0.1%	-81.1%	0.105%
5/16/2026	The Manufacturers Life Insurance Company	101,779	$1.49M	0.0%	+481.7%	0.121%
Do NOT Buy SpaceX – Do This Instead (Ad) SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. Read Tilson's free analysis and find out what to do with your money
5/16/2026	Quantinno Capital Management LP	22,982	$336K	0.0%	N/A	0.027%
5/15/2026	Commodore Capital LP	2,258,735	$33.05M	1.9%	N/A	2.686%
5/15/2026	Spruce Street Capital LP	231,585	$3.39M	0.8%	N/A	0.275%
5/14/2026	Renaissance Technologies LLC	81,310	$1.19M	0.0%	N/A	0.097%
5/14/2026	Sei Investments Co.	60,848	$890K	0.0%	N/A	0.072%
5/7/2026	SEB Asset Management AB	226,837	$3.32M	0.0%	N/A	0.270%
5/6/2026	Towerview LLC	70,000	$1.02M	0.7%	-50.0%	0.083%
5/5/2026	Bank of New York Mellon Corp	185,347	$2.71M	0.0%	+40.8%	0.220%
5/4/2026	Emerald Mutual Fund Advisers Trust	459,253	$6.72M	0.3%	N/A	0.546%
5/4/2026	Emerald Advisers LLC	686,216	$10.04M	0.3%	N/A	0.816%
5/4/2026	Teachers Retirement System of The State of Kentucky	8,000	$117K	0.0%	N/A	0.010%
4/29/2026	Shelton Wealth Management LLC	12,268	$179K	0.1%	-21.6%	0.015%
4/28/2026	Whittier Trust Co. of Nevada Inc.	10,200	$150K	0.0%	-8.9%	0.012%
4/27/2026	Simplify Asset Management Inc.	20,242	$296K	0.0%	N/A	0.024%
4/16/2026	SG Americas Securities LLC	35,420	$518K	0.0%	+76.9%	0.042%
3/20/2026	Hsbc Holdings PLC	59,269	$451K	0.0%	-28.1%	0.071%
2/19/2026	Invesco Ltd.	43,583	$336K	0.0%	+12.7%	0.052%
2/18/2026	Virtus Investment Advisers LLC	31,783	$245K	0.1%	+18.4%	0.038%
2/18/2026	Wellington Management Group LLP	314,683	$2.42M	0.0%	+74.7%	0.376%
2/18/2026	RTW Investments LP	447,607	$3.45M	0.0%	-83.3%	0.534%
2/18/2026	Perceptive Advisors LLC	692,441	$5.33M	0.1%	-51.9%	0.827%
2/18/2026	Millennium Management LLC	688,770	$5.30M	0.0%	N/A	0.822%
2/18/2026	Bridgeway Capital Management LLC	26,700	$206K	0.0%	-60.0%	0.032%
2/17/2026	Logos Global Management LP	500,000	$3.85M	0.2%	N/A	0.597%
2/17/2026	ADAR1 Capital Management LLC	465,875	$3.59M	0.3%	N/A	0.556%
2/17/2026	MPM Bioimpact LLC	2,743,671	$21.13M	2.4%	N/A	3.275%
2/17/2026	Price T Rowe Associates Inc. MD	34,105	$263K	0.0%	+5.2%	0.041%
2/17/2026	Captrust Financial Advisors	11,051	$85K	0.0%	N/A	0.013%
2/17/2026	Fred Alger Management LLC	144,381	$1.11M	0.0%	N/A	0.172%
2/17/2026	ExodusPoint Capital Management LP	86,720	$668K	0.0%	N/A	0.104%
2/17/2026	Graham Capital Management L.P.	19,274	$148K	0.0%	N/A	0.023%
2/17/2026	Foresite Capital Management VI LLC	1,381,233	$10.64M	3.2%	-20.2%	1.649%
2/16/2026	Squarepoint Ops LLC	104,820	$807K	0.0%	N/A	0.125%
2/16/2026	Truvestments Capital LLC	10,257	$79K	0.0%	+86.1%	0.012%
2/16/2026	Verition Fund Management LLC	21,382	$165K	0.0%	N/A	0.026%
2/16/2026	Barclays PLC	394,766	$3.04M	0.0%	+27.7%	0.471%
2/13/2026	Marshall Wace LLP	216,248	$1.67M	0.0%	N/A	0.258%
2/13/2026	The Manufacturers Life Insurance Company	17,497	$135K	0.0%	-6.6%	0.021%
2/13/2026	Rafferty Asset Management LLC	99,724	$768K	0.0%	N/A	0.119%
2/13/2026	Charles Schwab Investment Management Inc.	171,173	$1.32M	0.0%	-3.7%	0.204%
2/13/2026	State Street Corp	2,788,223	$21.47M	0.0%	+177.1%	3.328%
2/13/2026	Wells Fargo & Company MN	62,623	$482K	0.0%	+72.1%	0.075%
2/12/2026	DRW Securities LLC	23,384	$180K	0.0%	N/A	0.028%
2/12/2026	MetLife Investment Management LLC	30,782	$237K	0.0%	-8.4%	0.037%
2/12/2026	Alps Advisors Inc.	61,318	$472K	0.0%	N/A	0.073%
2/11/2026	DCF Advisers LLC	729,000	$5.61M	1.5%	N/A	0.870%
2/11/2026	Deutsche Bank AG	56,039	$432K	0.0%	+4.5%	0.067%
2/11/2026	Fox Run Management L.L.C.	11,220	$86K	0.0%	N/A	0.013%
2/10/2026	Goldman Sachs Group Inc.	553,327	$4.26M	0.0%	+24.2%	0.661%
2/10/2026	AXQ Capital LP	12,601	$97K	0.0%	-53.4%	0.015%
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
2/10/2026	Intech Investment Management LLC	35,973	$277K	0.0%	+37.5%	0.043%
2/9/2026	Geode Capital Management LLC	1,473,026	$11.35M	0.0%	+1.1%	1.758%
2/6/2026	ProShare Advisors LLC	13,764	$106K	0.0%	+7.7%	0.016%
2/4/2026	Towerview LLC	140,000	$1.08M	0.8%	-17.6%	0.167%
1/29/2026	China Universal Asset Management Co. Ltd.	18,169	$140K	0.0%	+39.1%	0.022%
1/26/2026	Shelton Wealth Management LLC	15,638	$120K	0.1%	+13.8%	0.021%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	3,629	$28K	0.0%	+26.0%	0.005%
1/21/2026	Palumbo Wealth Management LLC	26,255	$202K	0.0%	+11.2%	0.035%
1/21/2026	Sowell Financial Services LLC	17,000	$131K	0.0%	+41.7%	0.023%
1/16/2026	Tema Etfs LLC	79,698	$614K	0.0%	+34.6%	0.107%

CRVS Institutional Ownership - Frequently Asked Questions

During the previous two years, 135 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were BlackRock Inc. ($106.65M), Vivo Capital LLC ($41.05M), Wellington Management Group LLP ($40.81M), Perceptive Advisors LLC ($33.54M), Commodore Capital LP ($33.05M), Braidwell LP ($31.77M), and Orbimed Advisors LLC ($28.66M).Learn more on Corvus Pharmaceuticals' institutional investors.

46.64% of Corvus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Of the 125 institutional investors that purchased Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($7.14M), Perceptive Advisors LLC ($3.04M), MPM Bioimpact LLC ($2.74M), RTW Investments LP ($2.68M), Commodore Capital LP ($2.26M), State Street Corp ($1.84M), and Foresite Capital Management VI LLC ($1.73M).

Institutional investors have bought a total of 26,941,292 shares in the last 24 months. This purchase volume represents approximately $336.89M in transactions.

Of the 22 institutional investors that sold Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($2.23M), Perceptive Advisors LLC ($746.15K), ADAR1 Capital Management LLC ($377.97K), Foresite Capital Management VI LLC ($350K), Towerview LLC ($100K), Squarepoint Ops LLC ($79.69K), and Bridgeway Capital Management LLC ($40K).

Institutional investors have sold a total of 4,079,995 shares in the last 24 months. This volume of shares sold represents approximately $35.12M in transactions.

Related Companies

Institutional ownership data for NASDAQ:CRVS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corvus Pharmaceuticals (CRVS) Institutional Ownership

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

CRVS Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Corvus Pharmaceuticals (CRVS) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

CRVS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRVS shares?

What percentage of Corvus Pharmaceuticals' stock is owned by institutional investors?

Which institutional investors have been buying Corvus Pharmaceuticals' stock?

How much institutional buying is happening at Corvus Pharmaceuticals?

Which of Corvus Pharmaceuticals' major shareholders have been selling company stock?

How much institutional selling is happening at Corvus Pharmaceuticals?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools